Further analysis showed that six key EP‐Genes (SPP1, APOE, CLU, CST3, SERPINA1 and ALB) could be critical for the above pathological/biological effect, considering that the expression level of these six genes significantly correlated with the progression of FSGS. This evidence concerns the gene CLU and focal segmental glomerulosclerosis.